Last update 16 May 2025

Betamethasone Valerate/Gentamicin Sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
吉草酸ベタメタゾン/硫酸ゲンタマイシン, Betnoval G, DEXAN-VG
+ [8]
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesInfectious DiseasesCongenital Disorders+ [2]
Active Indication
Dermatitis, SeborrheicKeratoderma, PalmoplantarImpetigo+ [4]
Inactive Indication-
Originator Organization
Shionogi Pharma Co., Ltd.
Active Organization
Iwaki Seiyaku Co., Ltd.Iwaki Seiyaku Co., Ltd.Towa Pharmaceutical Co., Ltd.Towa Pharmaceutical Co., Ltd.Shionogi Pharma Co., Ltd.
+ [2]
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (31 Mar 1970),
DermatitisEczemaPsoriasis+ [1]
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC27H37FO6
InChIKeySNHRLVCMMWUAJD-SUYDQAKGSA-N
CAS Registry2152-44-5

Related

100 Clinical Results associated with Betamethasone Valerate/Gentamicin Sulfate
Login to view more data
100 Translational Medicine associated with Betamethasone Valerate/Gentamicin Sulfate
Login to view more data
100 Patents (Medical) associated with Betamethasone Valerate/Gentamicin Sulfate
Login to view more data
1
Literatures (Medical) associated with Betamethasone Valerate/Gentamicin Sulfate
01 Feb 1970Hifuka kiyo. Acta dermatologica
[Clinical experience with Rinderon VG ointment and the effect of gentamicin on skin surface bacterial count].
100 Deals associated with Betamethasone Valerate/Gentamicin Sulfate
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dermatitis, Seborrheic
Japan
Iwaki Seiyaku Co., Ltd.Iwaki Seiyaku Co., Ltd.
08 Feb 1988
Keratoderma, Palmoplantar
Japan
Iwaki Seiyaku Co., Ltd.Iwaki Seiyaku Co., Ltd.
08 Feb 1988
Impetigo
Japan
Shionogi Pharma Co., Ltd.
13 Jan 1975
Dermatitis
Japan
Shionogi Pharma Co., Ltd.
31 Mar 1970
Eczema
Japan
Shionogi Pharma Co., Ltd.
31 Mar 1970
Psoriasis
Japan
Shionogi Pharma Co., Ltd.
31 Mar 1970
Secondary infection
Japan
Shionogi Pharma Co., Ltd.
31 Mar 1970
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free